Jack Kain, PharmD
Jack Kain is director and medical science liaison of Drug Monitoring and Toxicology at Quest Diagnostics. He has served as a consultant, clinical toxicologist and medical science liaison for multiple toxicology laboratories.
Articles
CDC’s Proposed Opioid Prescribing Guideline: Does it Fall Short on Drug Testing?
April 18th 2022Last month, the Centers for Disease Control and Prevention shared a draft update to its Clinical Practice Guideline for Prescribing Opioids. The proposed revision comes as the nation’s overdose death rate reaches an all-time high, fueled largely by the economic and psychological strains and lack of healthcare access caused by COVID-19.
Read More
Latest Updated Articles
Published: February 25th 2025 | Updated: February 28th 2025
Gaps in Diabetes Patient Education and Rising Healthcare Costs
Published: February 16th 2025 | Updated: February 19th 2025
Many Aging Vietnam War Vets Are Still Battling PTSD, Along With Chronic Illnesses, That Combat Exposure May Make More Likely, New Research Finds
Published: February 5th 2025 | Updated: February 7th 2025
A Key Ingredient to ‘Food is Medicine’: Standardization
Published: January 30th 2025 | Updated: January 31st 2025
Evernorth Drives Cigna's Strong Revenue Growth and Focuses on Biosimilars and Drug Affordability
Published: July 2nd 2025 | Updated: July 14th 2025
Experts Push for Long-Term Solutions of Rural Hospital Fund Amid Senate Approval
Published: July 2nd 2025 | Updated: July 14th 2025
Dialysis Industry Is Now the Most Concentrated in Healthcare, Study Finds, With Prices Far Higher in Monopoly Areas
